(0.18%) 5 531.50 points
(0.12%) 39 516 points
(0.21%) 19 969 points
(0.58%) $82.01
(-2.11%) $2.55
(0.03%) $2 340.20
(-0.08%) $29.54
(-1.14%) $990.50
(-0.25%) $0.931
(-0.31%) $10.64
(-0.12%) $0.790
(1.95%) $87.40
Live Chart Being Loaded With Signals
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Šios dienos apimtis | 2.67M |
Vidutinė apimtis | 1.42M |
Rinkos kapitalizacija | 22.33B |
EPS | $0.840 ( Q1 | 2024-05-02 ) |
Kita pelno data | ( $2.00 ) 2024-07-30 |
Last Dividend | $0.240 ( 2024-06-26 ) |
Next Dividend | $0 ( N/A ) |
P/E |
23.54 (Sector) 49.64 (Industry) 37.79 |
ATR14 | $0.0840 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Kurdikar Devdatt | Buy | 0 | |
2024-05-31 | Yi Sang | Sell | 12 857 | Common Stock |
2024-06-01 | Stellato Paul A | Buy | 627 | Common Stock |
2024-06-01 | Stellato Paul A | Sell | 197 | Common Stock |
2024-06-01 | Stellato Paul A | Sell | 627 | Restricted Stock Units |
INSIDER POWER |
---|
-12.51 |
Last 99 transactions |
Buy: 115 496 | Sell: 148 958 |
Tūris Koreliacija
Zimmer Biomet Holdings Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
ELC | 0.823 |
EMP | 0.81 |
PSK | 0.803 |
MGR | 0.802 |
PFFD | 0.802 |
AFGB | 0.802 |
ENO | 0.801 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Zimmer Biomet Holdings Koreliacija - Valiuta/Žaliavos
Zimmer Biomet Holdings Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $7.39B |
Bruto pelnas: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2023 |
Pajamos: | $7.39B |
Bruto pelnas: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2022 |
Pajamos: | $6.94B |
Bruto pelnas: | $4.92B (70.90 %) |
EPS: | $1.390 |
FY | 2021 |
Pajamos: | $7.84B |
Bruto pelnas: | $5.50B (70.13 %) |
EPS: | $1.930 |
Financial Reports:
No articles found.
Zimmer Biomet Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.480 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0.240 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.175 | 2012-03-28 |
Last Dividend | $0.240 | 2024-06-26 |
Next Dividend | $0 | N/A |
Payout Date | 2024-07-31 | |
Next Payout Date | N/A | |
# dividends | 50 | -- |
Total Paid Out | $11.18 | -- |
Avg. Dividend % Per Year | 0.61% | -- |
Score | 4.34 | -- |
Div. Sustainability Score | 9.52 | |
Div.Growth Potential Score | 4.48 | |
Div. Directional Score | 7.00 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.700 | 1.34% |
2013 | $0.776 | 1.18% |
2014 | $0.856 | 0.96% |
2015 | $0.856 | 0.78% |
2016 | $0.932 | 0.94% |
2017 | $0.932 | 0.93% |
2018 | $0.932 | 0.77% |
2019 | $0.932 | 0.94% |
2020 | $0.932 | 0.64% |
2021 | $0.932 | 0.63% |
2022 | $0.960 | 0.77% |
2023 | $0.960 | 0.75% |
2024 | $0.480 | 0.40% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
26 Jun 2024 | $0.240 | 13 May 2024 | 26 Jun 2024 | 31 Jul 2024 |
27 Mar 2024 | $0.240 | 21 Feb 2024 | 29 Mar 2024 | 30 Apr 2024 |
28 Sep 2023 | $0.240 | 25 Aug 2023 | 29 Sep 2023 | 31 Oct 2023 |
26 Jun 2023 | $0.240 | 15 May 2023 | 26 Jun 2023 | 31 Jul 2023 |
23 Jun 2023 | $0.240 | 15 May 2023 | 26 Jun 2023 | 31 Jul 2023 |
28 Mar 2023 | $0.240 | 08 Mar 2023 | 29 Mar 2023 | 28 Apr 2023 |
23 Dec 2022 | $0.240 | 15 Dec 2022 | 27 Dec 2022 | 31 Jan 2023 |
29 Sep 2022 | $0.240 | 26 Aug 2022 | 30 Sep 2022 | 31 Oct 2022 |
24 Jun 2022 | $0.240 | 17 May 2022 | 27 Jun 2022 | 29 Jul 2022 |
28 Mar 2022 | $0.240 | 22 Feb 2022 | 29 Mar 2022 | 29 Apr 2022 |
27 Dec 2021 | $0.233 | 16 Nov 2021 | 28 Dec 2021 | 31 Jan 2022 |
29 Sep 2021 | $0.233 | 03 Sep 2021 | 30 Sep 2021 | 29 Oct 2021 |
25 Jun 2021 | $0.233 | 10 Jun 2021 | 28 Jun 2021 | 30 Jul 2021 |
26 Mar 2021 | $0.233 | 11 Mar 2021 | 29 Mar 2021 | 30 Apr 2021 |
24 Dec 2020 | $0.233 | 16 Dec 2020 | 28 Dec 2020 | 29 Jan 2021 |
29 Sep 2020 | $0.233 | 10 Sep 2020 | 30 Sep 2020 | 30 Oct 2020 |
26 Jun 2020 | $0.233 | 11 Jun 2020 | 29 Jun 2020 | 31 Jul 2020 |
26 Mar 2020 | $0.233 | 10 Mar 2020 | 27 Mar 2020 | 30 Apr 2020 |
26 Dec 2019 | $0.233 | 16 Dec 2019 | 27 Dec 2019 | 31 Jan 2020 |
27 Sep 2019 | $0.233 | 03 Sep 2019 | 30 Sep 2019 | 31 Oct 2019 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ECC | Dividend Diamond | 2024-07-11 | Monthly | 11 | 14.91% | 9.72 |
BRW | Dividend Diamond | 2024-06-11 | Monthly | 33 | 9.41% | 9.26 |
VVR | Dividend Diamond | 2024-06-18 | Monthly | 27 | 8.85% | 9.19 |
FCT | Dividend Diamond | 2024-06-03 | Monthly | 21 | 8.33% | 9.14 |
PHK | Dividend Diamond | 2024-06-13 | Monthly | 22 | 9.07% | 9.13 |
SBR | Dividend Diamond | 2024-06-17 | Monthly | 38 | 9.57% | 9.10 |
XFLT | Dividend Diamond | 2024-06-17 | Monthly | 8 | 10.49% | 9.09 |
SRV | Dividend Royal | 2024-07-16 | Monthly | 18 | 10.61% | 9.04 |
FAM | Dividend Royal | 2024-06-03 | Monthly | 20 | 8.07% | 8.98 |
RA | Dividend Diamond | 2024-06-11 | Monthly | 9 | 10.10% | 8.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.129 | 1.500 | 7.41 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0449 | 1.200 | 8.50 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0772 | 1.500 | -0.254 | -0.381 | [0.1 - 1] |
payoutRatioTTM | 0.207 | -1.000 | 7.93 | -7.93 | [0 - 1] |
currentRatioTTM | 1.656 | 0.800 | 6.72 | 5.38 | [1 - 3] |
quickRatioTTM | 0.658 | 0.800 | -0.837 | -0.670 | [0.8 - 2.5] |
cashRatioTTM | 0.141 | 1.500 | -0.331 | -0.496 | [0.2 - 2] |
debtRatioTTM | 0.270 | -1.500 | 5.50 | -8.25 | [0 - 0.6] |
interestCoverageTTM | 6.66 | 1.000 | 8.64 | 8.64 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.32 | 2.00 | 7.56 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.59 | 2.00 | 7.70 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.460 | -1.500 | 8.16 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.816 | 1.816 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.182 | 1.000 | 8.36 | 8.36 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.259 | 1.000 | 9.67 | 9.67 | [0.2 - 2] |
assetTurnoverTTM | 0.347 | 0.800 | -1.017 | -0.814 | [0.5 - 2] |
Total Score | 9.52 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 23.10 | 1.000 | 7.77 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0772 | 2.50 | -0.163 | -0.381 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.59 | 2.00 | 8.47 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.442 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.32 | 2.00 | 7.56 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.207 | 1.500 | 7.93 | -7.93 | [0 - 1] |
pegRatioTTM | -4.51 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.202 | 1.000 | 7.46 | 0 | [0.1 - 0.5] |
Total Score | 4.48 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.